Medpace Holdings (MEDP) | Stock Overview & Key Data
Medpace Holdings Performance Comparison
Stock Range
Today's Range
Low: $452.77
High: $465.72
on August 21, 2025
52 Week Range
Low: $250.05
High: $501.30
on April 22, 2025
on July 22, 2025
All-Time High: $501.30 on July 22, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$12.9B
EPS
13.46
P/E Ratio (TTM)
34.23
Forward P/E
36.88
P/B Ratio
74.89
PEG Ratio
3.15
Div. Yield
N/A
ROE
89.39%
Beta
1.429
Debt to Equity
86.93
Financial Highlights
Profitability
Gross Margin
29.84%
Operating Margin
20.94%
Profit Margin
18.74%
Returns and Earnings
Return on Assets (TTM)
17.09%
Return on Equity (TTM)
89.39%
EBITDA
$506.5M
Net Income (TTM)
$418.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$72.86
Quarterly Revenue Growth (YoY)
14.20%
Quarterly Earnings Growth (YoY)
2.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Medpace Holdings MEDP | 12.94B Large-cap | -1.16% | 46.77% | 53.27% | 33.25% | 35.43% | 15.97% | 185.19% | 254.59% |
| Thermo Fisher TMO | 184.10B Large-cap | -0.26% | 19.46% | 21.46% | -9.16% | -7.43% | -20.19% | -14.18% | 13.97% |
| Danaher DHR | 151.04B Large-cap | -3.01% | 8.42% | 9.15% | -3.01% | -11.27% | -24.34% | -17.95% | 11.85% |
| Idexx Laboratories IDXX | 50.94B Large-cap | -3.20% | 21.54% | 26.39% | 39.82% | 54.84% | 29.69% | 80.92% | 64.87% |
| Agilent Technologies A | 33.94B Large-cap | -1.45% | 4.56% | 7.57% | -13.46% | -12.20% | -16.84% | -9.79% | 17.27% |
| Iqvia Holdings IQV | 32.73B Large-cap | -2.12% | 16.63% | 35.04% | -2.96% | -4.99% | -25.53% | -15.61% | 14.99% |
Ownership & Short Interest
Insider Ownership
20.84%
Institutional Ownership
96.20%
Shares Short
3M
Short Ratio
3.60
Short % of Shares Outstanding
11.27%
Average 10-Day Volume
335K
Average 90-Day Volume
619K
Medpace Holdings Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Medpace Holdings would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MEDP's 52-week high and low?
- In the last 52 weeks, Medpace Holdings reached a high of $501.30 (on July 22, 2025) and a low of $250.05 (on April 22, 2025).
- What is the market cap and P/E ratio for MEDP?
- Curious about Medpace Holdings's size and valuation? Its market capitalization stands at 12.94B. When it comes to valuation, the P/E ratio (trailing twelve months) is 34.23, and the forward P/E (looking ahead) is 36.88.
- Does MEDP pay dividends? If so, what's the yield?
- As for dividends, Medpace Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medpace Holdings's main competitors or similar companies to consider before investing?
When looking at Medpace Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.10B Healthcare Diagnostics & Research -20.19% -14.18% Danaher
DHR151.04B Healthcare Diagnostics & Research -24.34% -17.95% Idexx Laboratories
IDXX50.94B Healthcare Diagnostics & Research 29.69% 80.92% Agilent Technologies
A33.94B Healthcare Diagnostics & Research -16.84% -9.79% Iqvia Holdings
IQV32.73B Healthcare Diagnostics & Research -25.53% -15.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medpace Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Medpace Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 89.39%, the Debt to Equity ratio from the most recent quarter is 86.93, and its Gross Profit Margin stands at 29.84%.
- What is the recent revenue and earnings growth for MEDP?
- Looking at Medpace Holdings's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.20%, and quarterly earnings saw a YoY growth of 2.20%.
- How much of MEDP stock is held by insiders and institutions?
- Wondering who owns Medpace Holdings stock? Company insiders (like executives and directors) hold about 20.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.20%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.